For research use only. Not for therapeutic Use.
6α-Methylprednisolone 21-hemisuccinate sodium salt(Cat No.:I000033)is a water-soluble corticosteroid derivative commonly used for its anti-inflammatory and immunosuppressive properties. This compound is a modified form of methylprednisolone, designed for rapid absorption and intravenous administration, making it suitable for acute conditions requiring immediate relief, such as severe allergic reactions, asthma, and autoimmune flare-ups. By inhibiting inflammatory pathways, it reduces swelling, pain, and immune responses. Its fast-acting nature and efficacy in controlling inflammation make 6α-Methylprednisolone 21-hemisuccinate sodium salt valuable in emergency and clinical settings for managing inflammatory and immune-mediated diseases.
Catalog Number | I000033 |
CAS Number | 2375-03-3 |
Synonyms | sodium 4-(2-((6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobutanoate |
Molecular Formula | C26H33NaO8 |
Purity | ≥95% |
Target | Glucagon Receptor |
Solubility | 10 mM in H2O |
Storage | Store at -20°C |
IUPAC Name | sodium;4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoate |
InChI | InChI=1S/C26H34O8.Na/c1-14-10-16-17-7-9-26(33,20(29)13-34-22(32)5-4-21(30)31)25(17,3)12-19(28)23(16)24(2)8-6-15(27)11-18(14)24;/h6,8,11,14,16-17,19,23,28,33H,4-5,7,9-10,12-13H2,1-3H3,(H,30,31);/q;+1/p-1/t14-,16-,17-,19-,23+,24-,25-,26-;/m0./s1 |
InChIKey | FQISKWAFAHGMGT-SGJOWKDISA-M |
SMILES | C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)[O-])O.[Na+] |